Renovo Health Natick, Massachusetts, United States
Session Description: This workship will immerse the attendee in the current issues related to the use of medication for addiction treatment (MAT). All three FDA-approved options will be discussed - methadone, buprenorphine, and naltrexone. An update will be provided on recently published clinical trials and trends in utiilization across the country. Controversies with the use of MAT will also be discussed including diversion, misuse, and co-prescribing with other controlled substances. Attendees will leave equiped with education and tools that will allow them to make optimal clinical decisions and appropriate recommendations to other clinicians.
Learning Objectives:
After this activity participants should be able to
Summarize recently published data related to the safety and efficacy of medication for addiction treatment (MAT).
Define the potential ratioanle for patients to divert their medication or to purchase it without a prescription.
List reasons as to why MAT is not currently utilized as the standard of care in the majority of patients with opioid use disorder (OUD).